[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Views 434
Citations 0
Correction
December 18, 2018

Errors in Figure

JAMA. 2018;320(23):2486. doi:10.1001/jama.2018.19142

In the Review article entitled “Venous Thromboembolism: Advances in Diagnosis and Treatment,” published in the October 16, 2018, issue of JAMA,1 errors were published in Figure 3. The box that reads “Indefinite anticoagulant therapy” should have included the footnote “a”; the box that reads “3 mo of anticoagulant therapy” should not have included the footnote “d”; and the box that reads “6 mo of anticoagulant therapy or as long as cancer is active” should have included the footnote “d” instead of “e.” In the figure caption, the published footnote “b” should not have appeared. Footnote “c” should have been “d” and the footnote should have read “Edoxaban, rivaroxaban, or low-molecular-weight heparin.” Footnote “d” should have been “b” and the footnote should have read “Recurrence risk according to the HERDOO2 rule.” Finally, footnote “e” should have been “c.” This article was corrected online.

References
1.
Tritschler  T, Kraaijpoel  N, Le Gal  G, Wells  PS.  Venous thromboembolism: advances in diagnosis and treatment.  JAMA. 2018;320(15):1583-1594. doi:10.1001/jama.2018.14346PubMedGoogle ScholarCrossref
×